#Immunity

Understanding how this variant helped people fend off the virus could lead to better ways to protect against COVID.

People with greater immune resilience may be at lower risk for severe COVID-19, AIDS and recurrent skin cancer, NIAID grantees find.

NIH-funded study suggests need to boost CD8+ T cell response after infection.

Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.

There is more to cancer immunotherapy than cytotoxic T cells.

In animal studies, introducing intestinal bacteria can promote anti-tumor immunity in the colon.

Severe short-term caloric restriction is safe for cancer patients and is associated with activation of immune responses.

The findings suggest boosters not only lengthen immunity but help broaden and strengthen the immune response.

Evidence is growing that contracting SARS-CoV-2 is generally as effective as vaccination at preventing COVID-19.

Younger adults and stem cell transplant recipients are at highest risk for measles and mumps.

Certain types of cancer treatment can lead to inadequate immune response.

Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.

Research suggests protective effect of natural infection or vaccination is likely to be persistent.

While the United States is getting closer to this point, most health experts caution, it still has ground to cover.

Natural immunity and vaccine responses may be weaker in people with immune suppression, so they should get their second dose promptly.

This is a good time to talk about how sleep can affect the body’s immune response to a vaccination.